Format

Send to

Choose Destination
Headache. 2018 Nov;58(10):1658-1669. doi: 10.1111/head.13414. Epub 2018 Oct 15.

Recommendations on the Use of Anti-CGRP Monoclonal Antibodies in Children and Adolescents.

Author information

1
Division of Neurology, Children's Hospital of Philadelphia & Departments of Neurology & Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
2
Mayo Clinic, Scottsdale, AZ, USA.
3
Cincinnati Children's Hospital Medical Center and Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
4
John's Hopkins University, Baltimore, MD, USA.
5
University of California, San Francisco, CA, USA.
6
Baylor College of Medicine, Houston, TX, USA.
7
Women's College Hospital and Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
8
Saint Louis University School of Medicine, St. Louis, MO, USA.
9
Lousiana State University Health Science Center and Children's Hospital New Orleans, New Orleans, LA, USA.
10
Akron Children's Hospital, Akron, OH, USA.
11
Nicklaus Children's Hospital, Miami, FL, USA.
12
University of Utah, Primary Children's Hospital, Salt Lake City, UT, USA.
13
UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA, USA.
14
Columbia University Medical Center, New York, NY, USA.
15
Feinberg School of Medicine at Northwestern University & Lurie Children's Hospital of Chicago, Chicago, IL, USA.
16
Children's Hospital Colorado, Aurora, CO, USA.

KEYWORDS:

adolescent; calcitonin gene-related peptide; migraine; monoclonal antibody; pediatric

PMID:
30324723
PMCID:
PMC6258331
[Available on 2019-11-01]
DOI:
10.1111/head.13414

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center